ANORO ELLIPTA (umeclidinium/vilanterol) Patient Assistance Program

Don’t let the high cost of brand specialty COPD inhalers disrupt your treatment. We help eligible patients access Anoro Ellipta (umeclidinium/vilanterol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Anoro Ellipta Prescription Assistance Program?

The Anoro Ellipta Prescription Assistance Program is a manufacturer-sponsored initiative that provides Anoro at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for COPD patients who are uninsured or underinsured.

Navigating the program on your own means dealing with eligibility verification, prescriber coordination, prior-authorization documentation (where insurance requires it), and renewal deadlines.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your breathing, not paperwork.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens

~$555.00

Save ~$485/inhaler

CVS Pharmacy

~$580.00

Save ~$510/inhaler

Walmart 

~$510.00

Save ~$440/inhaler

Costco

~$490.00

Save ~$420/inhaler

Kroger

~$500.00

Save ~$430/inhaler

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Anoro Ellipta Prescription Program?

The Patient Assistance Program is free to apply for and provides Anoro Ellipta at no medication cost if approved. But the process involves detailed applications, prescriber coordination, prior-authorization documentation, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, refill management, and annual re-enrollment.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Anoro Ellipta:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Coupon cards expire and require constant renewal
  •  Still $480–$580 per month even with the best discount
  • Can’t be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly through the assistance program
  • We manage all paperwork, refills, and annual renewals

  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Anoro Ellipta assistance.

Not sure if you qualify?  Our pre-qualification check is completely free. If we can’t help, you won’t be charged.

Understanding Anoro Ellipta:

Anoro Ellipta (umeclidinium/vilanterol) is a once-daily, fixed-dose combination dry-powder inhaler used for the long-term maintenance treatment of airflow obstruction in adults with COPD (chronic bronchitis and/or emphysema). It is not a rescue inhaler — patients with acute COPD exacerbations should still use a separate short-acting bronchodilator (such as albuterol).

How Anoro Ellipta Works:

COPD causes airflow obstruction through lung inflammation and structural changes like chronic bronchitis and emphysema. Anoro Ellipta uses two bronchodilators, Umeclidinium (LAMA) and Vilanterol (LABA), to target and relax the muscles surrounding the airways. By blocking constriction signals and activating relaxation receptors, this combination provides a full 24 hours of improved airflow.

Form and use:

This medication is a dry-powder inhaler administered as a single inhalation once daily at a consistent time. Each device contains a one-month supply of 30 doses and requires the user to rinse their mouth after use to prevent dry mouth. It is essential to remember that Anoro is for daily maintenance and should not be used as a rescue inhaler for sudden symptoms.

Generic availability:

As of 2026, there is no FDA-approved generic version of Anoro Ellipta available in the United States. While the exact generic is unavailable, several other LAMA/LABA combinations and single-agent inhalers exist on the market. Patients should consult their prescriber to determine which specific combination or alternative is most appropriate for their treatment plan.

Warnings:

Anoro Ellipta is not intended for acute respiratory distress, such as status asthmaticus or sudden COPD exacerbations. Users should monitor for serious side effects including heart palpitations, vision changes related to glaucoma, or worsening urinary retention. If you experience paradoxical bronchospasm—where breathing worsens immediately after use—or chest pain, notify a healthcare provider promptly.

FAQ (Frequently Asked Questions)

How Much Does Anoro Ellipta Cost Without Insurance?

The average retail price runs approximately $480–$580 per Ellipta inhaler (30 doses, one month). Through AffordMyPrescriptions, qualifying patients receive Anoro at no medication cost — our $69.95 monthly fee covers full advocacy and program management.

Anoro Ellipta combines a LAMA (umeclidinium) and a LABA (vilanterol) in one once-daily inhaler. Other LAMA/LABA combinations include Stiolto Respimat (tiotropium/olodaterol), Bevespi Aerosphere (glycopyrrolate/formoterol), and Duaklir Pressair (aclidinium/formoterol). Triple-therapy options (LAMA + LABA + ICS) include Trelegy Ellipta and Breztri Aerosphere. Whether one is a better fit depends on your COPD severity, exacerbation history, and inhaler-technique preference.

Open the cover until you hear a click. Breathe out fully (away from the inhaler). Place the mouthpiece in your mouth, close your lips around it, and inhale long and steadily. Hold your breath for 3–4 seconds. Close the cover. Rinse your mouth with water. The Ellipta tracks each dose automatically — the dose counter shows how many doses are left.

No. Anoro Ellipta is a maintenance inhaler — it is taken once daily on a regular schedule. It is not for the acute treatment of bronchospasm or sudden worsening of breathing. You should still have a separate short-acting rescue inhaler (typically albuterol) for sudden symptoms.

There are no generic Anoro Ellipta alternatives in the U.S. yet, but other LAMA/LABA combinations may have lower out-of-pocket cost depending on your insurance. Some formularies prefer specific LAMA/LABA brands. We can help you and your prescriber identify the most cost-effective inhaler that fits your COPD.

If your initial application is denied, we explore alternatives — the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the COPD Foundation, American Lung Association, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a different LAMA/LABA inhaler on a more accessible cost path would be appropriate. If we cannot find a path, you will not be charged our service fee.

Take Control of Your Medication Costs

If you are struggling with the high cost of Anoro Ellipta, our team may be able to help you access assistance programs designed to make brand specialty COPD inhalers affordable. Check your eligibility today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process